I ntricate mechanisms may contribute to the development of circulatory failure in septic shock, including hypovolemia, vasoplegia, and cardiac dysfunction (1) . This accounts for the need for optimal evaluation and monitoring of the hemodynamic status of patients with severe sepsis or septic shock. The Surviving Sepsis Campaign (SSC) has implemented graded recommendations to optimize hemodynamics in early sepsis (2) . These guidelines are mainly based on a randomized trial conducted in an emergency department prior to initial resuscitation, which showed that goal-directed management with targeted values of central venous pressure (CVP), mean arterial pressure, and central venous oxygen saturation (ScVO 2 ) significantly decreased hospital mortality in patients with sepsis-induced circulatory failure (3) . This approach remains controversial in the intensive care unit (ICU) setting (4) . CVP is a poor predictor of fluid responsiveness (5) . The detection of cardiac failure could be challenging because septic cardiomyopathy is not associated with markedly increased filling pressures (6) and tissue extraction abnormalities could lower the sensitivity of ScVO 2 in detection of low flow states (7) .
Over the last 20 yrs, echocardiography has gained a pivotal role in the hemodynamic assessment of ICU patients with cardiopulmonary compromise (8) . It rapidly provides unparalleled information on both the volume status and cardiac function of unstable patients (9) , and results in immediate therapeutic impact using standardized algorithms, especially in patients with septic shock (10) .
We sought to compare the therapeutic interventions derived from early echocardiographic assessment of hemodynamics Objective: To compare therapeutic interventions during initial resuscitation derived from echocardiographic assessment of hemodynamics and from the Surviving Sepsis Campaign guidelines in intensive care unit septic patients.
Design and Setting: Prospective, descriptive study in two intensive care units of teaching hospitals.
Methods: The number of ventilated patients with septic shock who were studied was 46. Transesophageal echocardiography was first performed (T1 < 3 hrs after intensive care unit admission) to adapt therapy according to the following predefined hemodynamic profiles: fluid loading (index of collapsibility of the superior vena cava ≥36%), inotropic support (left ventricular fractional area change <45% without relevant index of collapsibility of the superior vena cava), or increased vasopressor support (right ventricular systolic dysfunction, unremarkable transesophageal echocardiography study consistent with sustained vasoplegia). Agreement for treatment decision between transesophageal echocardiography and Surviving Sepsis Campaign guidelines was evaluated. A second transesophageal echocardiography assessment (T2) was performed to validate therapeutic interventions.
Results: Although transesophageal echocardiography and Surviving Sepsis Campaign approaches were concordant to manage fluid loading in 32 of 46 patients (70%), echocardiography led to the absence of blood volume expansion in the remaining 14 patients who all had a central venous pressure <12 mm Hg. Accordingly, the agreement was weak between transesophageal echocardiography and Surviving Sepsis Campaign for the decision of fluid loading (κ: 0. 37 Conclusions: A weak agreement was found in the prescription of fluid loading and inotropic support derived from early transesophageal echocardiography assessment of hemodynamics and Surviving Sepsis Campaign guidelines in patients presenting withand from SSC guidelines during the initial resuscitation of patients presenting with septic shock on ICU admission. We specifically hypothesized that discrepancies could exist between the two approaches in the initiation of fluid loading and inotropic support.
MATERIAL AND METHODS
Because transesophageal echocardiography (TEE) and central venous and arterial catheterizations are routinely performed in all patients with severe sepsis and septic shock in the two participating ICUs, our study was considered as part of routine clinical practice by the Ethics Committee of the "Société de Réanimation de Langue Française" (study number 08-237/CE-SRLF) and no informed consent was required from the patients or their next of kin.
The study was prospectively conducted over an 18-month period in the ICUs of two teaching hospitals. Patients were included in the study if they presented directly to the ICU with septic shock, without previous resuscitation in the emergency department, and if they required invasive mechanical ventilation. Septic shock was defined as sepsis associated with persistent hypotension after fluid loading (11, 12) or with the presence of clinical signs of tissue hypoperfusion confirmed by biochemical markers, such as elevated blood lactate or base deficit (13) . Exclusion criteria were a contraindication to TEE, ongoing pregnancy, age <18 yrs, or moribund state.
All studied patients underwent a diagnostic workup and therapeutic management of sepsis according to our standard of care. Before the third hour following ICU admission, the patient was sedated and put on mechanical ventilation. A central venous catheter was inserted in the internal jugular or subclavian vein, and blood pressure was monitored invasively. The correct position of the tip of the central venous catheter was confirmed by an anteroposterior chest radiography performed at the bedside. The carina was used as a landmark for detecting appropriate positioning of the central venous catheter at the junction of the superior vena cava and the right atrium (14) . All patients received at least 20 mL/kg of crystalloid in <1 hr. In the presence of a diastolic blood pressure <40 mm Hg (15), norepinephrine was immediately administered simultaneously to volume expansion at a starting dose of 0.125 μg/kg/min. Intravenous antibiotic therapy was started within the first 2 hrs after admission, after bacteriological sampling, and the entry site of infection was eradicated when indicated. Ventilatory settings were standardized as follows: tidal volume 8 mL/kg, positive end-expiratory pressure according to oxygenation variables and lung compliance (usually ≤10 cm H 2 O), and plateau pressure limited to 30 cm H 2 O. TEE was performed under the ongoing sedation used for mechanical ventilation, and muscle relaxants if necessary, to have the patient perfectly adapted to the respirator (T1). No change in sedation was made during the study period. The airway pressure and the electrocardiogram were displayed on the screen of the upper-end systems (Sequoia C 256, Siemens, PA and CX50 Philips Healthcare, Andover, MA), which were connected with a 5 or 7 MHz multiplane esophageal probe. In the four-chamber transesophageal view, we measured both the left ventricular (LV) and right ventricular (RV) end-diastolic area (EDA) and calculated the ratio of RV end-diastolic area and LVEDA. In the transgastric short-axis view at the midpapillary muscle level, we measured the LVEDA and LV end-systolic area and computed LV fractional area change (LVFAC) as (LVEDA−LV end-systolic area)/LVEDA. From this view, the probe was electronically rotated 110°-120° to measure pulse wave Doppler velocities of the ejection flow within the LV outflow track (16) . We then measured the velocity-time integral immediately above the aortic annulus and calculated the LV stroke volume by multiplying the velocity-time integral by the cross-sectional area of the LV outflow tract measured at the midesophageal view at 120° (17) . Cardiac output was obtained by multiplying the LV stroke volume by the heart rate. Finally, from a transesophageal 90° longitudinal examination of the superior vena cava, we measured the maximal diameter of the vessel during expiration and the minimal diameter during inspiration and calculated the superior vena cava collapsibility index (ΔSVC) as, (maximal diameter of the vessel during expiration−minimal diameter during inspiration)/maximal diameter of the vessel during expiration (18) .
The interpretation of the TEE examination performed at T1 led us to perform three therapeutic interventions based on distinct hemodynamic profiles, as a standard of care in our ICUs (Fig. 1) . Fluid loading was performed in the presence of marked respiratory variations of the superior vena cava, as reflected by a ΔSVC ≥36% (18) . Inotropic support was initiated or increased in the presence of septic cardiomyopathy characterized by an LVFAC <45% without relevant superior vena cava respiratory variations (19) . Increased vasopressor infusion was performed in the presence of RV systolic dysfunction defined as an RV end-diastolic area/LVEDA ratio >1 (20) and when persistent vasoplegia was the suspected mechanism for the circulatory failure. Sustained vasoplegia was suspected in the absence of TEE criteria for fluid loading and inotropic support, and in the absence of any other echocardiographic abnormality that could account for the circulatory failure associated with ongoing septic shock (e.g., acute valvular regurgitation secondary to an infective endocarditis, tamponade related to a purulent pericarditis).
During the TEE examination, systolic blood pressure, diastolic blood pressure, mean arterial pressure, CVP, and heart rate were recorded. Blood gases, base deficit, and lactate were measured in an arterial blood sample, and ScVO 2 was measured in a sample of blood obtained from the distal lumen of the central venous catheter. The physicians in charge of the patients were blinded to the values of ScVO 2 and CVP measured by the nurses until the patient completed the study period. Potential treatment interventions according to therapeutic targets of the SSC guidelines were virtually determined offline by an independent figure 1. Therapeutic interventions in the 46 included septic patients according to echocardiographic evaluation and Surviving Sepsis Campaign guidelines. ΔSVC, superior vena cava collapsibility index; LVFAC, left ventricular fractional area contraction, CVP, central venous pressure; MAP, mean arterial pressure; ScVO2, central venous oxygen saturation.
investigator who had no access to TEE results and interpretation (Fig. 1) .
A new TEE assessment (T2) was performed 90-180 mins after the hemodynamic optimization, which followed the initial TEE examination, to validate the therapeutic interventions decided at T1. Blood pressure, heart rate, CVP, blood gases, base deficit, lactate, and ScVO 2 were measured again.
In each patient, the Simplified Acute Physiology Score II (21) and the Sequential Organ Failure Assessment score (22) were calculated. The severity of an underlying medical condition was stratified according to the criteria of McCabe and Jackson (23) as rapidly fatal (2), ultimately fatal (1) or not fatal (0).
Statistical Analysis. Continuous variables were expressed as median (1st-3rd quartile). Between-group comparisons were performed using the Wilcoxon rank sum test for continuous variables. The agreement between the hemodynamic profiles determined at T1 from the TEE interpretation and according to SSC guidelines was assessed by means of unweighted Cohen's κ coefficient (95% confidence interval), interpretation of which is formalized by the table of Landis and Koch (24) . The concordance of the two approaches was considered as a disagreement (κ <0), very weak (κ, 0-0. 
RESULTS
During the study period, 62 mechanically ventilated patients with septic shock were screened and 46 were finally included. Sixteen patients were excluded as follows: seven patients were considered as moribund, seven patients had a contraindication to TEE (esophageal surgery, n = 4; esophageal varices: n = 3), and two patients were finally diagnosed with cardiogenic shock complicated by infection.
Demographic characteristics are presented in Table 1 . In 69% of cases, the infection was community acquired with a predominance of pneumonia. At the time of the initial TEE examination (T1), which was performed 2.0 (1.4-3.6) hrs after admission, 39 patients (85%) were receiving norepinephrine and five patients (11%) epinephrine. Lactate level was 3.2 (2.5-5.1) mmol/L and base deficit 7.7 (4.2-11.0) mmol/L (Table 2 ). Five patients (11%) fulfilled a single therapeutic target of the SSC, while 25 patients (54%) and 13 patients (28%) met two and three SSC criteria, respectively. The remaining patients (7%) were not in accordance with the SSC guidelines. The second TEE evaluation (T2) was performed 3.7 (2.5-5.6) hrs later to assess the efficacy of treatment interventions performed at T1. ICU mortality was 32%.
The main results are illustrated in Fig. 2 . Although TEE and SSC approaches were concordant to manage fluid loading in 32 of 46 patients (70%), echocardiography depicted a ΔSVC <36% in the remaining 14 patients who had a CVP <12 mm Hg (Fig. 2A) . Accordingly, the agreement for the decision of fluid loading was weak between echocardiography and the SSC, with a κ of 0.37 (0.16-0.59]. With a cut-off value <8 mm Hg for CVP, κ was 0.33 (−0.03 to 0.69) (see detais in Supplemental Figure 1 ; Supplemental Digital Content 1, http:// links.lww.com/CCM/A513). Inotropes were prescribed based on TEE assessment in 14 patients but would have been considered in only four patients according to SCC guidelines (Fig. 2B) . As a result, agreement between TEE and the SCC was weak, with a κ of 0.23 (−0.04 to 0.50). A disagreement (κ, −0.12 [−0.41 to 0.16]) was also observed between echocardiography and SCC for the initiation or increase of vasopressor support (Fig. 2C) because the latter was proposed in the absence of requirement of fluids or inotropes.
In the subset of patients who received fluid loading based on the presence of a ΔSVC ≥36% (43 [39] [40] [41] [42] [43] [44] [45] ] %) at T1, CVP was 8 (7-8) mm Hg and ScVO 2 81 (74-87) % (Table 3) . After fluid loading (T2, 3000 [1875-3125] mL), ΔSVC decreased to 13 (6-19) % and CVP increased to 13 (9-14) mm Hg, while cardiav index (CI) significantly increased from 2.1 (1.9-2.5) L/min/ m 2 at T1 to 2.5 (2.4-2.8) L/min/m 2 at T2 (Table 3) . Catecholamine infusions were substantially tapered. In the remaining 38 patients, ΔSVC was <36% (9 [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] %), while mean CVP was 14 (10-17) mm Hg and ScVO 2 79 (76-85) % (Table 3 ). All patients with a CVP≥ 12 mm Hg had a ΔSVC <36% (Fig. 3) .
No RV dysfunction was observed using TEE assessment at T1. Inotropic support was prescribed or increased based on the presence of LV systolic dysfunction (LVFAC, 24 [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] %) at T1 in 14 patients (30%). CVP was 15 (11) (12) (13) (14) (15) (16) (17) (18) (19) (Table 4) . No patient had anemia and only three patients had a ScVO 2 <70% (Fig. 4) . At T2, LVFAC significantly increased to 48 (39-61) %, CVP decreased to 9 (6-12) mm Hg, and CI rose to 2.4 (2.1-2.9) L/min/m 2 (Table 4 ). In half of the patients, base deficit decreased (7.6 [4. 5-8.7] mmol/L at T1 vs. 4.2 (2.6-6.8) mmol/L at T2), whereas it tended to increase in the remaining patients (8.5 [7.1-10.9] mmol/L at T1 vs. 10.3 [7.4-12.6 ] mmol/L at T2). The three patients with a ScVO 2 <70% at T1 had a partially or totally corrected ScVO 2 at T2. Among the remaining 32 patients with an LVFAC >45%, ScVO 2 was 75 (71-82) %, CVP 9 (7-13) mm Hg, and CI 2.4 (2.1-2.9) L/min/m 2 ( Table 4) .
DISCUSSION
The SSC implemented guidelines to improve the management of severe sepsis and septic shock, hence its prognosis (2) . Initial resuscitation relies on a stepby-step hemodynamic assessment leading to repeated goal-targeted therapeutic interventions. Fluid loading is recommended to obtain a CVP ≥12 mm Hg in mechanically ventilated patients, vasopressors should be titrated to obtain a mean arterial pressure ≥65 mm Hg, and a dobutamine infusion should be initiated if ScVO 2 is <70% despite the correction of an underlying anemia (2) . Substantial limitations of these guidelines, which are mainly based on a positive trial conducted in emergency department settings in patients who were seriously ill, as reflected by a mean ScVO 2 <50% and mean lactate >7 mmol/L (3), have been emphasized (4). In addition, ScVO 2 is usually in the normal to high range in septic patients because of an impaired oxygen extraction (7), as reported in recent clinical series (25) .
The present study showed that the agreement of therapeutic interventions derived from early echocardiographic assessment and SSC guidelines was weak regarding the prescription of fluid loading and positive inotropes in patients presenting to the ICU with severe sepsis or septic shock. According to our standard of care (10), we used a threshold value of ΔSVC ≥36% to perform blood volume expansion in our patients. This dynamic index has previously been shown to predict fluid responsiveness accurately in ventilated septic patients, with 100% specificity and 90% sensitivity (18) . Importantly, the second TEE assessment depicted a 23% increase of CI and a concomitant decrease in norepinephrine doses, thereby confirming the efficacy of fluid loading in this subset of patients. All our patients with a ΔSVC ≥36% who received fluids had an initial CVP <12 mm Hg, as previously suggested (5), but 14 of 38 patients with a ΔSVC <36% also had a CVP <12 mm Hg, suggesting the need for further blood volume expansion according to SSC guidelines (2) . Although CVP is routinely used on clinical grounds by a majority of intensivists, this variable has been widely shown to be inaccurate for the prediction of fluid responsiveness (5, 18, 26) . In addition, the cut-off value of 12 mm Hg targeted in the SSC guidelines is mainly supported by a 30-yr-old study performed in 15 patients with hypovolemic or septic shock (27) . The rationale for using CVP to guide fluid resuscitation is based on the hypothesis that the right atrial pressure accurately reflects right atrial blood volume. Nevertheless, in ventilated patients CVP is not altered only by the distending right atrial pressure (i.e., preload) but also by the transmitted positive intrathoracic pressure.
Early echocardiography disclosed LV systolic dysfunction in one third of the patients, a proportion similar to that reported in previous studies (6, 18, 28) .
On the basis of initial TEE findings, the administration of positive inotropes to these patients resulted in an 18% increase in CI, without any change in heart rate, and a significant decrease in CVP. The detection of LV dysfunction is based on the conjunction of elevated CVP (>12 mm Hg) and low ScVO 2 (<70%) in SSC guidelines (2) . Interestingly, CVP was <12 mm Hg in four of our 14 patients with echocardiographically documented LV systolic dysfunction, and a low ScVO 2 was observed in only three of them. These discrepancies are presumably related to the absence of marked elevation of cardiac filling pressures in the presence of septic cardiomyopathy and to impaired oxygen extraction in septic patients. In the landmark study of Parker et al (6) , pulmonary capillary occlusion pressure was similar in patients with or without sepsis-induced severe LV systolic dysfunction (14 ± 2 mm Hg vs. 13 ± 2 mm Hg). In 1990, Jardin et al (29) reported a mean CVP of 11 ± 3 mm Hg and a mean pulmonary capillary occlusion pressure of 11 ± 4 mm Hg in patients with echocardiographically documented septic cardiomyopathy, similar to those of patients with preserved LV systolic function. Recently, Bouhemad et al (30) reported similar values of pulmonary capillary occlusion pressure in patients with and without septic cardiomyopathy (10 ± 4 mm Hg and 11 ± 5 mm Hg, respectively). The absence of elevated cardiac filling pressures despite documented LV systolic dysfunction in septic patients is presumably explained by the transient increase in LV compliance because of the septic process (31, 32) . ScVO 2 is related to oxygen transport but also to tissue oxygen extraction. The latter is deeply impaired in severe sepsis (7) especially because of mitochondrial dysfunction (33) . In the randomized study by Gattinoni et al (34) performed in septic patients, mean SvO 2 was in the normal range in the entire population and remained unaffected by a strategy aimed at optimizing CI, when compared with the control group.
Recently, the implementation of the SSC guidelines has been shown to be associated with a 20% reduction in hospital mortality in the participating centers (35) . Similar results were also reported by Ferrer et al (36) . Nevertheless, SSC guidelines contain >80 recommendations that are not limited to hemodynamic resuscitation but rather encompass all aspects of the management of septic patients (2). In the above mentioned studies, the implementation of the SSC hemodynamic guidelines was not specifically associated with better survival in contrast to the guidelines concerning antibiotic management, administration of activated protein C in persistent shock, and tight glucose control (35, 36) . In the present study, the application of SSC guidelines would have led to fluid administration in 16 additional patients who had no TEE findings of preload dependency. ΔSVC is a fairly sensitive index of preload dependence because we reported only two false negatives out of 66 septic shock patients in a similar population of patients with septic cardiomyopathy (18) . Increasing evidence supports the deleterious effect of excessive fluid loading on the prognosis of ICU patients (37, 38) . Specifically, Boyd et al (38) showed that a positive fluid balance during the first 4 days of ICU hospitalization and the presence of an elevated CVP were independent factors of death, the highest mortality rate being observed in the subset of patients with a CVP >12 mm Hg at hour 12 after admission. In the present study, 30% of patients were diagnosed with LV systolic dysfunction during the initial TEE assessment, which prompted the administration of positive inotropes. Small studies have suggested that in the presence of LV systolic dysfunction, patients who have a preserved cardiovascular response to inotropic stimulation, as reflected by a positive response to low-dose dobutamine, have a better survival (39) (40) (41) . Accordingly, the accurate detection of septic cardiomyopathy using early TEE in septic patients with organ hypoperfusion could be valuable in guiding the intensivist to initiate inotropic support, whereas no study has clearly demonstrated the value of dobutamine. In addition, systematic optimization of cardiac output has long been known to have deleterious effects (34) . According to SSC guidelines, inotropic support is highly recommended in the presence of a CVP >12 mm Hg and an ScVO 2 <70%, which are suggestive of LV systolic dysfunction. The present data suggest that relevant LV systolic dysfunction may be clearly disclosed by TEE in patients who fail to meet SSC criteria to receive inotropic support.
This study has several limitations. First, the relatively small size of our population precludes definitive conclusions and it remains to be seen how our results can be applied to spontaneously breathing patients. In the study of Rivers et al (3) , only half of the septic patients were mechanically ventilated. Second, our study shows that treatment decisions are heavily influenced by the type of monitoring and guidelines used but fails to provide information on their potential impact on outcome. Third, our definition of LV systolic dysfunction is somewhat arbitrary but is based on our previous experience (10, 19) . Importantly, a consistent improvement in hemodynamics after inotropic support was observed in this subset of patients. Finally, as opposed to the SSC guidelines, which were designed to be applicable anywhere, echocardiography is not yet readily accessible in all ICUs, and intensivists must be adequately trained to use our approach in the early management of patients presenting with severe sepsis or septic shock (42, 43) .
CONCLUSIONS
We found that initial hemodynamic monitoring with echocardiography might result in less fluid loading and more use of inotropes than SSC guidelines in ventilated patients presenting to the ICU with septic shock. Our findings should be confirmed in a larger, more statistically robust population and further studies are required to evaluate the potential impact of these strategies on outcome.
